Impax, Medicis Clear Up Acne Patent Dispute
Impax Laboratories Inc. will be able to move forward with marketing a generic version of the acne medication Solodyn now that the company has resolved its patent battle with Medicis Pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article